Company intelligence / Profile preview

Genophyll Enterprises

Central New Jersey, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

Genophyll Labs is a certified clinical laboratory in New Jersey specializing in rapid, reliable COVID-19 RT-PCR testing using nasal swabs, with an average turnaround time of 12–24 hours. The company emphasizes accessibility, especially for high-risk community members, and is working to expand into next-generation genomic tests for cancer and rare diseases in the future. Genophyll Labs is notable for being one of the few woman, minority, and 'Gen-Z' owned laboratories in the state, and for its commitment to advocacy and modern patient communication.

Therapeutic areas: Infectious Diseases
Modalities: RT-PCRNext Generation Sequencing (NGS)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Genophyll Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genophyll Enterprises.

Explore the full profile